Glycosylation of Pilin and Nonpilin Protein Constructs by Pseudomonas aeruginosa 1244

PilO is an oligosaccharyl transferase (OTase) that catalyzes the O-glycosylation of Pseudomonas aeruginosa 1244 pilin by adding a single O-antigen repeating unit to the β carbon of the C-terminal residue (a serine). While PilO has an absolute requirement for Ser/Thr at this position, it is unclear if this enzyme must recognize other pilin features. To test this, pilin constructs containing peptide extensions terminating with serine were tested for the ability to support glycosylation. It was found that a 15-residue peptide, which had been modeled on the C-proximal region of strain 1244 pilin, served as a PilO substrate when it was expressed on either group II or group III pilins. In addition, adding a 3-residue extension culminating in serine to the C terminus of a group III pilin supported PilO activity. A protein fusion composed of strain 1244 pilin linked at its C terminus with Escherichia coli alkaline phosphatase (which, in turn, contained the above-mentioned 15 amino acids at its C terminus) was glycosylated by PilO. E. coli alkaline phosphatase lacking the pilin membrane anchor and containing the 15-residue peptide was also glycosylated by PilO. Addition of the 3-residue extension did not allow glycosylation of either of these constructs. Site-directed mutagenesis of strain 1244 pilin residues of the C-proximal region common to the group I proteins showed that this structure was not required for glycosylation. These experiments indicate that pilin common sequence is not required for glycosylation and show that nonpilin protein can be engineered to be a PilO substrate.Colonization and dissemination of the opportunistic pathogen Pseudomonas aeruginosa rely to a large extent on the ability of this organism to produce functional type IV pili (26). These protein fibers, which radiate from the cell pole, are adhesion factors (51), mediate a form of surface translocation referred to as twitching motility (10, 37), and are important in biofilm formation (39). The pili of this organism are primarily composed of a monomeric subunit called pilin (PilA). Type IV pili can be differentiated into two classes (a or b) on the basis of the PilA sequence and structure (23). Although they display considerable sequence variation, the majority of the type IVa pilins of P. aeruginosa can be placed into one of three groups on the basis of primary structure and antigenicity, as well as by the presence of auxiliary pilin genes found immediately downstream from pilA (8, 33). We previously determined that pilin from P. aeruginosa 1244, which belongs to group I (8), contained an O-antigen repeating unit covalently attached to the β-hydroxyl group of a serine residing at the C terminus of this protein (7). While the specific physiological role of the pilin glycan in this organism is not clear, the presence of this saccharide influences pilus hydrophobicity and has a pronounced effect on virulence, as determined in a mouse respiratory model (47). The metabolic origin of the pilin saccharide is the O-antigen biosynthetic pathway (14), and its attachment is catalyzed by an oligosaccharyl transferase (OTase) called PilO (6). Specific regions of this cytoplasmic membrane protein necessary for glycosylation activity have been identified (42). Topological studies of PilO have shown that these regions face the periplasm, suggesting that pilin glycosylation takes place in this chamber (42). Here the glycan substrate is the O-antigen repeating unit covalently linked to the undecaprenol carrier lipid.PilO has a very relaxed glycan substrate specificity, as indicated by the evidence that it is able to utilize a number of structurally dissimilar O-antigen repeating units as substrate (14), and requires only features of the reducing end sugar to carry out pilin glycosylation (28). WaaL, the enzyme that transfers polymerized O antigen to core lipid A, from Escherichia coli also has a similar broad glycan specificity (19). Recent studies (18) provided evidence that PglL, an OTase of Neisseria meningitidis, recognized only the carrier lipid and was able to attach a variety of saccharides to the pilin of this organism. Although the glycan specificity of PilO is relaxed, this enzyme will not attach other carrier lipid-bound saccharides, such as the peptidoglycan subunit or polymerized O-antigen repeating unit, to pilin. This is indicated by the absence of pilins with increased mass in O-antigen-negative mutants or the production of multiple pilin sizes in the wild-type strain (6).In vivo analysis of mutagenized P. aeruginosa 1244 pilin showed that the C-terminal serine of this protein was a major pilin glycosylation recognition feature of PilO (27). In addition, modification (substitution of the C-terminal amino acid with a 3-residue sequence terminating in serine) of a group II pilin allowed PilO-dependent attachment of the O-antigen repeating unit (27). While these results suggested that the preponderance of pilin structural information was not required for glycosylation, it was not clear whether regions common among the P. aeruginosa pilins were needed. In the present study three types of experiments were carried out in order to answer this question. First, the glycosylation site was extended away from the pilin surface with the addition of a 15-residue peptide which terminates with serine. Second, an engineered periplasmic protein containing the glycosylation residue at its C terminus was fused with pilin and tested for PilO activity. Finally, this periplasmic protein containing no pilin common region was constructed and tested. Evidence presented in this paper suggests that PilO requires only the glycosylation target residue.The work presented also indicated that, in addition to pilins, nonpilin protein free in the periplasm or anchored to the cytoplasmic membrane could be engineered so as to serve as a PilO substrate. These results suggest that a wide range of pilins and nonpilin proteins can be engineered to serve as substrate for glycosylation, a finding that would potentially have practical value, particularly in the area of vaccine construction. In addition to elucidating the protein specificity of the PilO system, the present work determined that the peptide extension used can supply functional epitope information to the modified protein, in addition to providing a site for glycosylation. Altogether, the results presented suggest that engineering of pilins and nonpilin proteins for the biological generation of protein-peptide-saccharide constructs is a potentially important strategy in vaccine design.